跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SODIUM CHLORIDE INHALATION SOLUTION USP 0.9% - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SODIUM CHLORIDE INHALATION SOLUTION USP 0.9%
Authorized
STANDARD
SODIUM CHLORIDE INHALATION SOLUTION USP 0.9%
The Ritedose Corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
04dee7fce701f6ed
Company
The Ritedose Corporation
Type
Standard
Approval Details
Approval Id
04dee7fce701f6ed
Drug Approval Canada Name
SODIUM CHLORIDE INHALATION SOLUTION USP 0.9%
Product Name
SODIUM CHLORIDE INHALATION SOLUTION USP 0.9%
Status
Cancelled Post Market
Status Date
2017-06-05
Original Market Date
1994-12-31
Din
02058235
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Inhalation
Schedule
Ethical
Ahfs
40:36.00
Atc Original
B05CB01 SODIUM CHLORIDE
Atc Name
b 05 cb 01
Aig Number
0100053002
Company Name
The Ritedose Corporation
Company Address
1 Technology Circle, Columbia, South Carolina, United States, 29203-9591
Company Detail Path
/organization/the-ritedose-corporation
Company Information
Pharmaceutical Company Name
The Ritedose Corporation
Country Name
United States
Province Name
South Carolina
City Name
columbia,south carolina,country_us
Address
1 Technology Cir
Active Ingredients
SODIUM CHLORIDE
0.9 %
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
04dee7fce701f6ed
Type
Standard
Back to Health Canada Approvals
